CAS 1612191-86-2

Fórmula: C25H44O3

InChI: InChI=1S/C25H44O3/c1-5-17-21-14-16(27)8-11-25(21,4)20-9-12-24(3)18(15(2)10-13-26)6-7-19(24)22(20)23(17)28/h15-23,26-28H,5-14H2,1-4H3/t15-,16-,17-,18-,19+,20+,21+,22+,23-,24-,25-/m1/s1

Clave InChI: HYCMOIGNYNCMRH-APIYUPOTSA-N

SMILES: CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCO)C)C)O

BAR502

CAS: 1612191-86-2

BAR502

Fórmula: C₂₅H₄₄O₃

Pureza: ≥98%

Peso molecular: 392.62

Ref: 54-BUP04705

24-Norcholane-3,7,23-triol, 6-ethyl-, (3α,5β,6α,7α)-

CAS: 1612191-86-2

Fórmula: C₂₅H₄₄O₃

Pureza: 98%

Forma y color: Solid

Peso molecular: 392.6151

Ref: IN-DA00AR2H

BAR502

CAS: 1612191-86-2

BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM).

Fórmula: C₂₅H₄₄O₃

Pureza: 99.95%

Forma y color: Solid

Peso molecular: 392.6151

Ref: TM-TQ0252

BAR502

CAS: 1612191-86-2

Fórmula: C₂₅H₄₄O₃

Peso molecular: 392.62

Ref: 4Z-C-57111

BAR502

CAS: 1612191-86-2

Fórmula: C₂₅H₄₄O₃

Peso molecular: 392.6

Ref: BE-RMCC229015

BAR 502-d5

Producto controlado

CAS: 1612191-86-2

Fórmula: C₂₅H₃₉D₅O₃

Forma y color: Neat

Peso molecular: 397.646

Ref: TR-B161226

BAR502

Producto controlado

CAS: 1612191-86-2

BAR502 is a drug that is used in clinical trials as a treatment for chronic liver disease. BAR502 activates the nuclear receptor PPARγ, which has been shown to improve insulin sensitivity in animals with chronic liver disease. The mechanism of action of BAR502 has not been fully elucidated, but it may be due to its ability to decrease lipid accumulation and improve glucose tolerance in adipose tissue. BAR502 binds to PPARγ receptors and alters the expression of genes involved in energy metabolism, such as fatty acid synthase and gluconeogenic enzymes. The clinical relevance of BAR502 has not yet been determined.

Fórmula: C₂₅H₄₄O₃

Pureza: Min. 95%

Peso molecular: 392.62 g/mol

Ref: 3D-MPC19186